ArticleBMJ public health2025
Initiation of opioid agonist treatment following hospital-treated opioid toxicities and the risk of repeat events in Ontario, Canada: a cohort study using inverse probability of treatment weights.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of opioid agonist therapies on non-fatal and fatal overdose: treatment patterns among individuals with opioid use disorder in Ontario, Canada.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The period following hospital discharge for opioid toxicity presents an increased risk for repeat events. While opioid agonist treatment (OAT) can reduce this risk, in-hospital initiation rates remain low, and the impact of early initiation on subsequent repeat toxicities is not well understood. Methods: We conducted a population-based cohort study of Ontario residents discharged following a hospital-treated opioid toxicity between 1 January 2014 and 31 December 2021, followed to 31 July 2022. The exposure was OAT initiation within 30 days of discharge, with a subgroup analysis of OAT initiation within 1 day. The primary outcome was repeat opioid toxicity within 6 months. Stabilised inverse probability treatment weighting (sIPTW) was used to balance baseline covariates, and Cox proportional hazards models to assess the association between OAT initiation and hazard of repeat events. Results: Our cohort included 20 523 opioid toxicities of which 68.5% were male, with a mean age of 36.5 years. Before sIPTW, important differences were observed, including more prior year opioid toxicities (mean 1.35 vs 1.05; standardised difference (Std Diff)= 0.18) and greater public drug benefit eligibility (70.1% vs 58.1%; Std Diff=0.25) among the exposed. Overall, 2544 people (12.4%) initiated OAT within 30 days of hospital discharge. In weighted models, people who initiated OAT in the month following discharge had a lower hazard of repeat toxicity (1.62 per 1000 person-days) compared with those who did not (2.04 per 1000 person-days; weighted HR=0.57; 95% CI 0.47 to 0.69). Findings were consistent in our subgroup analysis (weighted HR=0.44; 95% CI 0.57 to 0.91). Conclusions: Among the small proportion who initiated OAT after a hospital-treated opioid toxicity, there was a significant reduction in repeat toxicities, emphasising the importance of early OAT initiation. To facilitate this, care pathways between hospital and community must be strengthened through enhanced investments in addiction medicine training, hospital resources and reducing stigma in hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.